Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Moderna’s COVID-19 vaccine touted as strongly effective by FDA advisers

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/13 at 10:47 AM
Share
SHARE

The American-based biotechnology company Moderna has received the nod from a panel of advisers over at the Food and Drug Administration (FDA), paving the way for an alternative COVID-19 vaccination option.

According to the FDA report, the praise obtained for Moderna’s new COVID-19 vaccine (mRNA-1273) came on the heels of a EUA request submitted as confirmed cases had surged on a mere daily basis in the U.S.

As part of an ongoing Phase 3 randomized, double-blinded trial, so far the new experimental vaccine has demonstrated efficiency at combatting the novel coronavirus, enough for FDA advisers to recommend its approval for immediate use.

“An EUA request for a COVID-19 vaccine should include all safety data accumulated from studies conducted with the vaccine, with data from Phase 1 and 2 focused on serious adverse events, adverse events of special interest, and cases of severe COVID-19 among study participants,” the report reads.


“The Phase 1 and 2 safety data likely will be of a longer duration than the available safety data from the Phase 3 trial at the time of submission of an EUA request and thus, are intended to complement the available data from safety follow-up from ongoing Phase 3 studies,” the report also states.

Thus far, the strongest vaccinational candidates against COVID-19 has centered around Pfizer-BioNTech, along with Sputnik V; however, Moderna’s mRNA-1273 may be similarly effective as both of those vaccines, the Moderna findings claim.

You Might Also Like

Machine learning research suggests drugs that may decrease cigarette smoking

New research explores the association between viral infection and Alzheimer’s disease

Study suggests mindfulness may help adolescents overcome traumas

Researchers find pregnancy length is shorter among Americans than Europeans

Study suggests gut microbes may control body temperature

TAGGED: COVID-19, epidemiology, Moderna, fda
Staff Writer December 17, 2020
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article New tryptophan discovery may help improve diagnosis of severe mental illness
Next Article People with high ADHD traits are more likely to experience insomnia

Recommended

Health

Machine learning research suggests drugs that may decrease cigarette smoking

1 Min Read
Health

New research explores the association between viral infection and Alzheimer’s disease

1 Min Read
Health

Study suggests mindfulness may help adolescents overcome traumas

1 Min Read
Health

Researchers find pregnancy length is shorter among Americans than Europeans

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?